When treatments are unavailable, and prognoses are fatal, the best chance to prolong life is to consider all remaining options.
Stringent regulations on the e-cigarette market to come.
Right-to-try will never reach its potential without deregulation.
Recent events indicate an urgent need for researchers and policymakers to relearn the basics.
FDA launches anti-vaping campaign.
The only reliable remedy to mitigate shortages of any product is to allow competition in the market.
FDA behind the market in delivering contraceptive apps.
Off-label information policy reform works to broaden what information drug providers can share.
Right-to-try, MDMA, and Epidolex provide examples of the power of public opinion to change the scope of government.
FDA regulation holds part of the blame for high drug prices.